Hot on the heels of the Trial of the Year awards, Clinical Trials: Impact & Quality (CT:IQ) held its inaugural symposium with many members of the Awards audience joining in.
CT:IQ has been driven by industry and has ACTA as a foundation partner. It will work to advance projects spanning the clinical trials sector – commercial and investigator-initiated – that are distinct from ACTA’s work supporting clinical trials networks, coordinating centres, and registries. CT:IQ’s foundation partners, also including The George Institute and CTC ,will work together on coordination.
Modelled on the highly successful US FDA-funded Clinical Trials Transformation Initiative(CTTI), CT:IQ is co-funded by MTPConnect and brings together industry stakeholders “ … to fund big, bold ideas to drive growth through collaboration and commercialisation in the medical technology, biotechnology and pharmaceutical sector.”
If you are keen to stay in touch with CT:IQ, sign up here ensuring you tick “Register for the CT:IQ eNews” on the contact form.